HB 1600, now effective as law in Oklahoma since May 22, 2025, establishes 19 specific rights for all patients receiving medical care in the state, including respectful treatment, clear communication about treatment options, advance directive support, privacy, and visitor rights. It also outlines patient responsibilities, such as providing accurate health information and participating in care planning. The law requires hospitals to inform patients of these rights and their complaint processes, replacing prior guidelines with enforceable statutory standards. This bill directly affects every patient in Oklahoma healthcare facilities and all hospitals providing care under state law.
SB 993 regulates how pharmacy benefit managers (PBMs) audit pharmacies in Oklahoma. It requires PBMs to provide 14 days' notice (30 days for wholesale audits) before audits, prohibits treating simple clerical errors (like typos or computer mistakes) as fraud, and bans recouping funds for such errors without proof of intentional fraud. The bill also mandates that if funds are recouped, pharmacies must refund patients first, and PBMs must conduct audits using licensed pharmacists for clinical judgments. This directly affects pharmacies and PBMs by setting clear standards for audit processes and preventing unfair financial penalties.
SB 518 requires medical marijuana businesses in Oklahoma to use specific warning labels on all products sold to licensed patients. The labels must include mandatory statements like "For use by licensed medical marijuana patients only," "Keep out of reach of children," and warnings about driving under influence and pregnancy risks, along with potency details (THC/cannabinoids) and contaminant testing information. The law prohibits child-targeted packaging (such as cartoon characters) and bans health benefit claims on product containers. It applies to all medical marijuana businesses and takes effect November 1, 2025, after becoming law without the governor's signature on May 21, 2025.
SB 253 requires Oklahoma's Medicaid agency (the Oklahoma Health Care Authority) to include specific funding details in its annual budget request. It mandates that the budget reflect new state and federal funding needed to cover the most recent audited costs for reimbursing nursing facilities and intermediate care facilities serving individuals with intellectual disabilities. The audited cost must be calculated using the latest cost report submitted to the agency. This change takes effect November 1, 2025.
HB 1658 regulates laser hair removal practitioners in Oklahoma by requiring all providers to use only FDA-approved devices and hold specific licenses or certifications. It mandates a 40-hour training program for practitioners (completed internally or via third parties under physician oversight), requires facilities to be overseen by a physician (with exemptions for Advanced Practice Registered Nurses), and establishes protocols for patient evaluations, informed consent, and complication management. The law also specifies that physicians must be available for real-time communication during procedures but need not be physically present. This bill directly affects laser hair removal practitioners, clinics, and supervising physicians, becoming effective immediately upon passage as an emergency measure.
SB 723 updates Oklahoma law to clarify which positions at the Oklahoma Department of Veterans Affairs are exempt from standard civil service rules. It adds 11 specific healthcare and administrative roles - including physician assistants, pharmacists, occupational therapists, and Veterans Center administrators - to the list of exempt positions. The bill removes outdated references to previous exemption methods and confirms existing exempt positions remain unaffected. This change takes effect November 1, 2025.
SB 786 prohibits consuming marijuana or possessing open marijuana containers in the passenger area of any moving vehicle on public roads, and bans inhaling secondhand marijuana smoke while driving. It increases the trauma-care fee for violations from $100 to $250, requiring payment into Oklahoma's Trauma Care Assistance Fund. The law applies to all drivers on public highways, streets, or alleys, with exemptions only for buses and limousines (where drivers still cannot consume alcohol or marijuana). It became law without the governor's signature on May 14, 2025, and takes effect November 1, 2025.
SB 391 extends the Opioid Overdose Fatality Review Board's existence until July 1, 2026 (correcting the bill title's "dissolving" error), requiring it to review opioid overdose cases involving adults. The Board gathers confidential records from medical examiners, hospitals, law enforcement, and other agencies to identify systemic issues in medical or law enforcement responses, then makes recommendations for improvement. All case discussions and recommendations remain confidential and privileged, not admissible in court, while the Board must publish an annual public report by February 1 detailing its findings and system coordination. This directly affects state agencies (like mental health services, law enforcement, and medical examiners) and ensures public transparency through annual reports.
HB 1811 changes Oklahoma insurance rules for chronic condition care. It requires insurers to keep prior authorizations valid for six months for non-inpatient treatments (like outpatient care) and 14 days for inpatient acute care. For ongoing inpatient stays, insurers must approve extensions within 72 hours or continue paying providers; they cannot use stricter criteria than the initial approval. The law does not require coverage for conditions already excluded from policies.
HB 2047, the Emerson Kate Cole Act, updates Oklahoma school medication policies to improve safety for students with allergies and asthma. It requires school districts to adopt policies allowing students to self-administer prescribed asthma inhalers, epinephrine for allergic reactions, and cystic fibrosis medications, with written parental permission and physician documentation. Key provisions include mandating annual staff training on recognizing allergic reactions and administering epinephrine, requiring schools to notify parents after medication use, and specifying protocols for stocking and using epinephrine injectors (including 911 contact procedures). The bill also creates model policies for districts to follow and clarifies that schools and staff incur no liability for medication administration under these guidelines. This law, effective May 14, 2025, directly affects public school districts, students with chronic conditions, and their families.
